
Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. (STOK) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · STOK · as of Jun 8, 2026
Key Statistics
Explore Stoke Therapeutics, Inc. Data
stok stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 15 · Buy rate: 80.0%
The STOK analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $43.86, representing +51.24% upside from the current price of $29.00.
Competitors & Peers
stok competitorsStock Performance
Full HistoryAbout Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. is an emerging biopharmaceutical company dedicated to developing innovative antisense oligonucleotide (ASO) therapies. Its primary focus is to target and address the fundament…
what is stoke therapeutics, inc. · stok stock overview · stoke therapeutics, inc. company profile · who is stoke therapeutics, inc. ceo · stok NASDAQ · stoke therapeutics, inc. headquarters · stoke therapeutics, inc. business segments
About Stock Overview & Key Data
Stoke Therapeutics, Inc. (STOK) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 19, 2019. As of the latest trading session, STOK stock price is $29.00, with a market capitalization of $1.8B. The stock has returned +161.55% over the past 12 months and -8.29% year-to-date.
According to 15 Wall Street analysts, the consensus rating for Stoke Therapeutics, Inc. stock is Buy, with an average 12-month price target of $43.86. In fiscal year 2025, Stoke Therapeutics, Inc. reported revenue of $184.4M and net income of -$6.9M. For detailed data — including Stoke Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Stoke Therapeutics, Inc. (STOK) stock price is $29.00. The stock is traded on NASDAQ under the ticker symbol STOK. The 52-week range is $10.63 – $40.22.